Yigal Nochomovitz
Stock Analyst at Citigroup
(3.39)
# 993
Out of 5,031 analysts
310
Total ratings
45.53%
Success rate
4.44%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Yigal Nochomovitz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RCUS Arcus Biosciences | Maintains: Buy | $47 → $54 | $16.47 | +227.87% | 8 | Oct 13, 2025 | |
| MRUS Merus | Downgrades: Neutral | $101 → $97 | $94.89 | +2.22% | 17 | Sep 29, 2025 | |
| AVBP ArriVent BioPharma | Maintains: Buy | $40 → $33 | $19.51 | +69.14% | 3 | Aug 12, 2025 | |
| ARCT Arcturus Therapeutics Holdings | Maintains: Buy | $47 → $49 | $20.66 | +137.17% | 6 | Aug 12, 2025 | |
| OLMA Olema Pharmaceuticals | Maintains: Buy | $20 → $21 | $9.36 | +124.36% | 2 | Aug 12, 2025 | |
| ZLAB Zai Lab | Maintains: Buy | $66 → $69 | $28.27 | +144.12% | 9 | Aug 11, 2025 | |
| BMEA Biomea Fusion | Maintains: Buy | $9 → $7 | $1.51 | +363.58% | 10 | Aug 11, 2025 | |
| ZYME Zymeworks | Maintains: Buy | $19 → $22 | $18.40 | +19.57% | 17 | Aug 11, 2025 | |
| LXRX Lexicon Pharmaceuticals | Maintains: Buy | $1.2 → $1.9 | $1.42 | +33.80% | 12 | Aug 7, 2025 | |
| SNDX Syndax Pharmaceuticals | Maintains: Buy | $46 → $51 | $14.30 | +256.64% | 9 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $176 → $166 | $190.23 | -12.74% | 6 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $52 | $24.52 | +112.07% | 17 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $49 → $52 | $38.26 | +35.91% | 4 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sell | $7 | $22.51 | -68.90% | 1 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $9 | $2.97 | +203.03% | 2 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $14 | $5.88 | +138.10% | 1 | Jun 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $9.5 | $9.52 | -0.21% | 10 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $10 | $5.03 | +98.81% | 15 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $23 → $35 | $20.99 | +66.75% | 5 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $49 → $55 | $27.94 | +96.85% | 11 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $25 | $5.33 | +369.04% | 1 | Feb 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $89 → $82 | $69.15 | +18.58% | 21 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $33 | $11.63 | +183.75% | 1 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $8 | $1.28 | +525.00% | 10 | Nov 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $6 | $2.63 | +128.14% | 5 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $27 | $23.95 | +12.73% | 1 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $8 → $2 | $1.81 | +10.50% | 4 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $58 | $29.26 | +98.22% | 3 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $14 | $1.65 | +748.48% | 14 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.5 → $1.2 | $1.48 | -18.92% | 9 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $14 | $12.78 | +9.55% | 6 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.8 → $2 | $2.78 | -28.06% | 3 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $8 | $5.26 | +52.09% | 10 | Oct 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.5 → $1 | $4.97 | -79.88% | 4 | Sep 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $50 → $35 | $14.81 | +136.33% | 12 | Aug 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $130 → $133 | $32.64 | +307.54% | 15 | Jun 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $16 | $3.98 | +302.01% | 3 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $10 | $1.47 | +580.27% | 6 | Mar 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $44 | $3.41 | +1,190.32% | 2 | Sep 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $12 | $2.17 | +453.00% | 1 | Sep 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $5.47 | - | 14 | Sep 28, 2021 |
Arcus Biosciences
Oct 13, 2025
Maintains: Buy
Price Target: $47 → $54
Current: $16.47
Upside: +227.87%
Merus
Sep 29, 2025
Downgrades: Neutral
Price Target: $101 → $97
Current: $94.89
Upside: +2.22%
ArriVent BioPharma
Aug 12, 2025
Maintains: Buy
Price Target: $40 → $33
Current: $19.51
Upside: +69.14%
Arcturus Therapeutics Holdings
Aug 12, 2025
Maintains: Buy
Price Target: $47 → $49
Current: $20.66
Upside: +137.17%
Olema Pharmaceuticals
Aug 12, 2025
Maintains: Buy
Price Target: $20 → $21
Current: $9.36
Upside: +124.36%
Zai Lab
Aug 11, 2025
Maintains: Buy
Price Target: $66 → $69
Current: $28.27
Upside: +144.12%
Biomea Fusion
Aug 11, 2025
Maintains: Buy
Price Target: $9 → $7
Current: $1.51
Upside: +363.58%
Zymeworks
Aug 11, 2025
Maintains: Buy
Price Target: $19 → $22
Current: $18.40
Upside: +19.57%
Lexicon Pharmaceuticals
Aug 7, 2025
Maintains: Buy
Price Target: $1.2 → $1.9
Current: $1.42
Upside: +33.80%
Syndax Pharmaceuticals
Aug 5, 2025
Maintains: Buy
Price Target: $46 → $51
Current: $14.30
Upside: +256.64%
Aug 5, 2025
Maintains: Neutral
Price Target: $176 → $166
Current: $190.23
Upside: -12.74%
Aug 1, 2025
Maintains: Buy
Price Target: $46 → $52
Current: $24.52
Upside: +112.07%
Aug 1, 2025
Maintains: Buy
Price Target: $49 → $52
Current: $38.26
Upside: +35.91%
Jul 24, 2025
Initiates: Sell
Price Target: $7
Current: $22.51
Upside: -68.90%
Jul 9, 2025
Maintains: Buy
Price Target: $6 → $9
Current: $2.97
Upside: +203.03%
Jun 26, 2025
Initiates: Buy
Price Target: $14
Current: $5.88
Upside: +138.10%
May 5, 2025
Maintains: Neutral
Price Target: $10 → $9.5
Current: $9.52
Upside: -0.21%
May 2, 2025
Maintains: Buy
Price Target: $11 → $10
Current: $5.03
Upside: +98.81%
Mar 26, 2025
Upgrades: Buy
Price Target: $23 → $35
Current: $20.99
Upside: +66.75%
Mar 6, 2025
Maintains: Buy
Price Target: $49 → $55
Current: $27.94
Upside: +96.85%
Feb 20, 2025
Initiates: Buy
Price Target: $25
Current: $5.33
Upside: +369.04%
Feb 18, 2025
Maintains: Buy
Price Target: $89 → $82
Current: $69.15
Upside: +18.58%
Jan 7, 2025
Initiates: Buy
Price Target: $33
Current: $11.63
Upside: +183.75%
Nov 29, 2024
Maintains: Buy
Price Target: $13 → $8
Current: $1.28
Upside: +525.00%
Nov 26, 2024
Maintains: Buy
Price Target: $30 → $6
Current: $2.63
Upside: +128.14%
Oct 8, 2024
Initiates: Buy
Price Target: $27
Current: $23.95
Upside: +12.73%
Oct 2, 2024
Downgrades: Neutral
Price Target: $8 → $2
Current: $1.81
Upside: +10.50%
Aug 27, 2024
Maintains: Buy
Price Target: $60 → $58
Current: $29.26
Upside: +98.22%
Aug 15, 2024
Maintains: Buy
Price Target: $16 → $14
Current: $1.65
Upside: +748.48%
Jun 18, 2024
Maintains: Neutral
Price Target: $3.5 → $1.2
Current: $1.48
Upside: -18.92%
May 7, 2024
Maintains: Buy
Price Target: $15 → $14
Current: $12.78
Upside: +9.55%
Apr 18, 2024
Maintains: Neutral
Price Target: $1.8 → $2
Current: $2.78
Upside: -28.06%
Oct 17, 2023
Maintains: Buy
Price Target: $25 → $8
Current: $5.26
Upside: +52.09%
Sep 18, 2023
Maintains: Neutral
Price Target: $1.5 → $1
Current: $4.97
Upside: -79.88%
Aug 21, 2023
Maintains: Sell
Price Target: $50 → $35
Current: $14.81
Upside: +136.33%
Jun 7, 2023
Maintains: Buy
Price Target: $130 → $133
Current: $32.64
Upside: +307.54%
Apr 5, 2023
Maintains: Buy
Price Target: $24 → $16
Current: $3.98
Upside: +302.01%
Mar 2, 2023
Maintains: Buy
Price Target: $9 → $10
Current: $1.47
Upside: +580.27%
Sep 16, 2022
Maintains: Buy
Price Target: $45 → $44
Current: $3.41
Upside: +1,190.32%
Sep 16, 2022
Maintains: Buy
Price Target: $16 → $12
Current: $2.17
Upside: +453.00%
Sep 28, 2021
Upgrades: Buy
Price Target: n/a
Current: $5.47
Upside: -